focus -WSS

focus

author：Wikipedia 2025-08-28 08:40:02 - browse：17792

Balance innovation — Medicare laid out in the greatest detail yet how it will choose which drug prices it will negotiate in its brand-new program, and how it will figure out what the government’s opening offer will be. Adobe

WASHINGTON — Medicare laid out Wednesday in the greatest detail yet how it will choose which drug prices it will negotiate in its brand-new program, and how it will figure out what the government’s opening offer will be.

Democrats outlined some parts of the process in the Inflation Reduction Act that passed Congress last August, but the details of how drugs will be selected and what factors will be considered have been vague until now. Though the actual negotiated prices won’t take effect for years, Medicare officials must announce the first 10 drugs they’ll negotiate over by Sept. 1.

The guidance clarifies that the agency will choose the 50 pharmacy drugs that cost Medicare the most money, based on gross expenditures. If drugs have the same cost to the program, then the one that has been approved longer will be ranked higher.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： BioMarin wins approval for gene therapy to treat hemophilia A
Next article： PBMs drew scrutiny in House hearing — and so did pharma

knowledge

WSS

Grad students accuse University of California of wage theft

Nobel honors Karikó and Weissman's enduring partnership

Study points to new risk in gene therapy death of Terry Horgan

What will Novo Nordisk's VC do with its influx of cash?

House panel takes first step toward fixing drug shortages

Why the drug industry's warnings on the IRA's impact fall short

knowledge

focus

focus

Heart attack and stroke risk calculators need revising

Information blocking fines are now fair game in health care

In Memoriam: Notable people who died in 2023

Nobel honors Karikó and Weissman's enduring partnership

Anesthesiologist group: stop taking Ozempic before surgery

The Karikó problem: Lessons for funding basic research

Medicare details structure of new drug price negotiation program

Eli Lilly CEO gives to Mike Pence presidential super PAC

The high cost of giving birth even with insurance

PBMs drew scrutiny in House hearing — and so did pharma

knowledge

Study points to new risk in gene therapy death of Terry Horgan

Stop Congress from blocking public access to science

Flu, Covid vaccination rates decline, new survey data show

David Liu startup to focus on CRISPR delivery

2023 Nobel Prize in Medicine goes to Karikó and Weissman

The biotech scorecard for Q4: 16 stock

explore

knowledge

Wikipedia

explore